DAY ONE BIOPHARMACEUTICALS I (DAWN)
US23954D1090 - Common Stock
ChartMill assigns a Buy % Consensus number of 79% to DAWN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 36.08. This target is 141.84% above the current price.
DAWN was analyzed by 17 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about DAWN.
In the previous month the buy percentage consensus was at a similar level.
DAWN was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-25 | Needham | Reiterate | Buy -> Buy |
| 2024-04-24 | Needham | Maintains | Buy -> Buy |
| 2024-04-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-26 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-27 | Oppenheimer | Reiterate | Perform -> Perform |
| 2024-02-27 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-11-07 | Needham | Reiterate | Buy -> Buy |
| 2023-11-07 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-09-12 | Needham | Reiterate | Buy -> Buy |
| 2023-09-12 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-08-08 | Needham | Reiterate | Buy |
| 2023-08-08 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-05 | Needham | Reiterate | Buy -> Buy |
| 2023-06-05 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-06-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-08 | Needham | Maintains | Buy |
| 2023-05-02 | Needham | Reiterate | Buy |
| 2023-04-25 | B of A Securities | Downgrade | Buy -> Underperform |
| 2023-04-05 | Needham | Maintains | Buy |
| 2023-03-07 | Needham | Reiterate | Buy |
| 2023-03-07 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-08 | Capital One | Initiate | Overweight |
| 2023-02-03 | Oppenheimer | Initiate | Perform |
| 2023-01-09 | Goldman Sachs | Maintains | Buy |
| 2023-01-09 | Piper Sandler | Maintains | Overweight |
| 2023-01-09 | HC Wainwright & Co. | Maintains | Buy |